Bridgepoint announced the promotion of six colleagues to Partner
This recognizes exceptional contributions and strengthens the firm's presence in key markets.
See the latest news and media coverage for Bridgepoint. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global middle-market alternative asset manager
bridgepointgroup.comLast updated
In short: Bridgepoint expanded its portfolio through key acquisitions, including Obagi Medical and iC Consult, while delivering strong annual financial results.
This recognizes exceptional contributions and strengthens the firm's presence in key markets.
The acquisition builds on Bridgepoint's track record in dermatology and aesthetics, with expected close in Q3 2026.
The transaction is subject to regulatory approval; financial terms undisclosed. Bridgepoint reinvests as minority shareholder via its Growth II fund.
Interpath appoints Chris Woodhouse as Chair. The firm scales internationally with over 1,000 professionals across 14 countries.
Waldencast Obagi sale, Bridgepoint acquisition, Obagi Medical skincare, Milk Makeup strategy, dermatology skincare market, beauty portfolio restructuring...
ICG PLC (LSE:ICG) and Bridgepoint Group PLC (LSE:BPT) were among several fund groups on both sides of the Atlantic to see their shares fall after...
Waldencast plc (NASDAQ: WALD) ("Waldencast" or "the Company") today announced that it has entered into a definitive agreement to sell its Obagi Medical dermatological skincare...
Bridgepoint Group Plc is set to raise about €5 billion ($5.8 billion) to target financing opportunities in Europe’s direct lending market, people with knowledge of...
Track Bridgepoint and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Bridgepoint and other trending companies.